Resume Company – The Internet’s Very Best
The Following Text Is An Unformatted Professional Resume Sample
From The Writers At The Resume Writing Group, Inc.
This Resume Has Not Been Formatted
ORDER YOUR OWN LETTER-PERFECT, JOB-WINNING RESUME AND IT WILL BE COMPLETED AS SOON AS YOU NEED!
Click HERE!
0000 xxxxxx xxxx , xxxx , xxxxx 00000 xxx-xxx-xxxx abc@xyz.com
Driven, respected, and versatile Research Director with exceptional communication and organizational skills; well prepared to excel as a Medical Science Liaison
Neuroscience Neurophysiology Pharmaceuticals
Staff Management Project Management Product Development
Sound knowledge of clinical trials process, risk management, drug safety, and quality assurance.
Able to engage scientific leaders by exhibiting advanced clinical acumen to earn rapid credibility.
Proven ability to disseminate and present complex scientific concepts in broad therapeutic settings.
Recently earned Certification in Medical Communications from Drug Information Association and currently completing courses in Communication Skills for Aspiring MSLs with Medical Liaison Society.
Completed multiple leadership training courses during career with Allergan.
Versatile, client-focused, highly collaborative, and excel at interpreting complex medical data.
Highly skilled at communicating with people from diverse cultures and backgrounds.
Solid knowledge of the drug development process and government regulations.
Well-developed analytical, troubleshooting, documentation, reporting, and organizational skills
Draw upon strong interpersonal skills to train, direct, supervise, motivate and empower cross-functional personnel to achieve business goals.
Knowledge of ICH guidelines, GCP and other ethical guidelines relevant to pharmaceutical industry.
Able to adapt, organize, prioritize, and work effectively in a constantly changing environment.
Professional Experience
Allergan, Inc., Irvine, CA, 2007 to 2017
Research Director, Neurotoxins Research 2015 to 2017
Confirmed novel botulinum toxin shared same potency as Botox in rat compound muscle action potential (cMAP) studies to provide company justification to advance molecule into phase 1 clinical trials.
Spearheaded rat cMAP studies on novel botulinum toxin to demonstrate mechanism of action and shed light on unexplained results observed in a phase 1 clinical trial.
Led development of behavioral in vivo studies used to assess actions of two novel botulinum toxins that represented investigations into efficacy of toxins in two new therapeutic areas.
Elucidated scientific data among six project teams and performed experiments in two new therapeutic areas using two novel methods of application.
Served as integral member of group charged with overseeing cutting-edge vivarium facility.
Joined forces with stakeholders across Development, Regulatory, Commercial, and Clinical groups to achieve mutual goals.
Principal Scientist 2010 to 2015
Directed in vivo rodent behavioral pain studies to study novel, recombinant botulinum neurotoxin using GPCR ligand as targeting moiety versus native binding domain; effectively convinced company to advance molecule into phase 2 clinical trials for post-herpetic neuralgia.
Championed comprehensive data analysis from rodent pain studies to explore novel retargeted botulinum neurotoxin in models of inflammatory pain.
Performed whole-cell patch clamp electrophysiology and calcium imaging studies on primary neuronal cultures and develop alternative methods to measure botulinum toxin inhibitory effects on muscle function.
Continued ►
Yyyyyy x. yyyyyy Page 2 of 2
Senior Scientist 2007 to 2010
Methodically planned and conducted whole-cell patch clamp electrophysiology and calcium imaging studies on primary neuronal cultures and cell lines to investigate mechanism of action of botulinum toxin type A and retargeted botulinum toxins.
Applied dynamic leadership talents toward mentoring, supervising, and coaching up to six scientists.
Valeant Pharmaceuticals - Costa Mesa, CA, 2005 to 2007
Research Scientist
Conducted electrophysiology experiments to prove potassium channel opener, retigabine (Potiga), does not affect cardiac subtypes of potassium channel targeted by retigabine (KCNQ/Kv7); collaboratively and successfully justified ultimate FDA approval as an anticonvulsant in treatment-resistant patients.
Prior Background:
Research Scientist, Burnham Research Institute - San Diego, CA
Research Fellow, Merck Research Labs - San Diego, CA
Principal Research Scientist, SIBIA Neurosciences, Inc. - La Jolla, CA
CSO, NeurOp, Inc - Atlanta, GA
Education
Post-doctoral Fellowship: Molecular, physiological and pharmacology of glutamate receptors
Emory University, Pharmacology Department - Atlanta, GA
Post-doctoral Fellowship: Physiology and pharmacology of rat midbrain dopaminergic neurons, Parke-Davis Division of Warner Lambert, Pharmacology Dept. - Ann Arbor, MI
PhD, Neuroscience, Characterization of Muscarinic and GABAergic Responses in Rat Basolateral Amygdala Neurons, University of Michigan - Ann Arbor, MI
BA, Biology, Lawrence University - Appleton, WI
Memberships
Drug Information Association
Medical Science Liaison Society
Society for Neuroscience
American Autonomic Society
International Association for the Study of Pain
Awards
Allergan Awards for Excellence
Small Business Innovation Research (SBIR) Grant Recipient - NeurOp, Inc., Atlanta, GA
NRSA Postdoctoral Fellowship, Emory University, Atlanta, GA
Rackham Block Grant, University of Michigan
Rackham Predoctoral Fellowship, University of Michigan
NIMH Traineeship, University of Michigan
~ Publications and presentations available upon request ~
<< Previous Back to Sitemap Next >>
Remember: Hire Us To Write YOUR New Resume
And We GUARANTEE That If You’re Not Working In 60 Days Or Less,
We’ll Revise Your Resume, Refund Your Money,
AND Give You $50 EXTRA!
